Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FLAMENT, Jocelyne")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

The number and activity of mammary epithelial cells, determining factors for milk production : Galactopoiesis and milk productsBOUTINAUD, Marion; GUINARD-FLAMENT, Jocelyne; JAMMES, Hélène et al.Reproduction, nutrition, development (1989). 2004, Vol 44, Num 5, pp 499-509, issn 0926-5287, 11 p.Conference Paper

The INFUSE-Morphine IIB Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneous Morphine in Healthy VolunteersTHOMAS, Jay R; YOCUM, Richard C; HALLER, Michael F et al.Journal of pain and symptom management. 2009, Vol 38, Num 5, pp 673-682, issn 0885-3924, 10 p.Article

Oxytocin and milk removal: two important sources of variation in milk production and milk quality during and between milkings : Milk protein and lipid production in mammalian cellsLOLLIVIER, Vanessa; GUINARD-FLAMENT, Jocelyne; OLLIVIER-BOUSQUET, Michèle et al.Reproduction, nutrition, development (1989). 2002, Vol 42, Num 2, pp 173-186, issn 0926-5287, 14 p.Conference Paper

Changes in mammary uptake and metabolic fate of glucose with once-daily milking and feed restriction in dairy cows : Mammary gland and milkGUINARD-FLAMENT, Jocelyne; DELAMAIRE, Eloise; LEMOSQUET, Sophie et al.Reproduction, nutrition, development (1989). 2006, Vol 46, Num 5, pp 589-598, issn 0926-5287, 10 p.Conference Paper

The INFUSE-Morphine Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneously Administered Morphine in Patients with Advanced IllnessTHOMAS, Jay R; WALLACE, Mark S; YOCUM, Richard C et al.Journal of pain and symptom management. 2009, Vol 38, Num 5, pp 663-672, issn 0885-3924, 10 p.Article

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatmentOSSELAER, Jean C; MESSE, Nathalie; CORASH, Laurence et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 6, pp 1061-1071, issn 0041-1132, 11 p.Article

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated setJANETZKO, Karin; CAZENAVE, Jean-Pierre; LIN, Lily et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 9, pp 1443-1452, issn 0041-1132, 10 p.Article

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia : a pilot studySIMONSEN, Anne C; JOHANSSON, Pär I; CONLAN, Maureen G et al.Transfusion (Philadelphia, PA). 2006, Vol 46, Num 3, pp 424-433, issn 0041-1132, 10 p.Article

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trialVAN RHENEN, Dick; GULLIKSSON, Hans; LIOURE, Bruno et al.Blood. 2003, Vol 101, Num 6, pp 2426-2433, issn 0006-4971, 8 p.Article

  • Page / 1